Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline March 7, 2026 Crypto Market Update: Wall Street Deepens Crypto Stake with US$25 Billion OKX Deal March 7, 2026 Venezuela Gold Set for US Market in Brokered Deal March 7, 2026
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline March 7, 2026